Crohn’s Disease Market: Current Analysis and Forecast (2022-2028)
Emphasis on Diagnostics (Blood tests, Feacal tests, Colonoscopies, Flexible Sigmoidoscopy, Computerized tomography, Magnetic resonance imaging and others) and Treatment (Medication, Surgery); and Region/Country
The Crohn’s Disease market was valued at 15 Bn abd is expected to grow at a strong CAGR of around 3% during the forecast period (2022-2028) owing to the acquisition activities between the pharmaceutical companies. For instance, in 2022, Pfizer completed the acquisition of Arena Pharmaceutical a clinical trial development clinical-stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases. Furthermore, this Acquisition would offer a new, differentiated, and potentially best-in-class approach to address the needs of a broader number of patients with immuno-inflammatory diseases including Crohn’s disease. Thus, the above-mentioned element is anticipated to boost the market growth for Crohn’s disease in the forecast period.
Some of the major players operating in the market include Takeda Pharmaceutical Company Limited., Janssen Global Services, LLC, UCB S.A., Biogen, AbbVie Inc., Genentech, Inc., Gilead Sciences, Inc. Eli Lilly and Company, Pfizer Inc., and Johnson & Johnson Services, Inc.
Insights Presented in the Report
“Amongst diagnostics, the computerized tomography segment is growing with significant CAGR in 2021 market”
Based on diagnostics, the market is segmented into blood tests, faecal tests, colonoscopies, flexible sigmoidoscopy, computerized tomography, magnetic resonance imaging and others. Amongst these, the computerized tomography segment is anticipated to grow with a significant CAGR in the forecast period. Computerized tomography provides great benefits to medical care. This technology improves diagnostics, prevents unnecessary medical procedures, and provides detailed anatomical information about the disease at a cost-effective rate. Additionally, it provides quick and easy diagnosis during emergency cases, including images of the extent of damage to the internal organ. This provides the healthcare professional with the status of the disease based upon which the healthcare professional can design a suitable treatment. Thus, the above-mentioned factor is anticipated to fuel the market growth in the forecast period.
“Amongst treatment, the surgical segment is growing with a significant CAGR in the market in 2021”
Based on the treatment, the market is bifurcated into medication and surgery. Amongst these, the surgical segment is anticipated to grow with a significant CAGR in the forecasted period. This is attributed to the advancement in surgical techniques, for the management of Crohn’s disease. The evolution of Crohn’s disease has led to improve outcomes and reduce morbidity. Additionally, the demand for minimal-invasive surgeries such as robotic-assisted surgeries, and laparoscopies has led to faster recovery over time, shorter hospital stays and ultimately improved patient outcomes.
“North America dominated the Crohn’s Disease market in 2021”
North America is anticipated to grow with a significant CAGR in the 2021 market. This is attributed towards treatment advancements and improved diagnostics awareness. The advancement in diagnostics and increasing awareness about pre-diagnostics have led to accurate diagnostics for Cohn’s disease. As a result, more patients are identifying and seeking appropriate treatment. Furthermore, the advancements in novel therapies and treatments for Cohn’s disease have led to market expansion. The introduction of immunomodulators, biologics and targeted therapy systems has provided more appropriate options for the management of the disease condition leading to market growth. Thus, the above-mentioned elements are fueling the market growth in this region.
Crohn’s Disease Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global Crohn’s Disease market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Crohn’s Disease Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Crohn’s Disease market were the three major steps undertaken to create and analyze the adoption of Crohn’s Disease in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Crohn’s Disease market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Crohn’s Disease market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Crohn’s Disease market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as diagnostics and treatment. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Crohn’s Disease market. Further, we conducted factor analysis using dependent and independent variables such as diagnostics, and treatment of the Cronh’s disease market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Crohn’s Disease market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Crohn’s Disease market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the Crohn’s Disease market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global Crohn’s Disease market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Crohn’s Disease market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of diagnostics, and treatment in the global Crohn’s Disease market.
The main objective of the Global Crohn’s Disease Market Study
The current & future market trends of the global Crohn’s Disease market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the Crohn’s Disease market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of the diagnostics and treatment
- Define and analysis of the regulatory framework for the Crohn’s Disease industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the Crohn’s Disease market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the Crohn’s Disease market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
